PHILADELPHIA, Dec. 9, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to be appointed as a lead ...

San Diego, California--(Newsfile Corp. - December 9, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until Friday, January 16, 2026 to seek appointment as lead plaintiff of the Perrigo class action lawsuit. Captioned French v. Perrigo Company plc, No. 25-cv-09596 (S.D.N.Y.), the Perrigo class action lawsuit charges Perrigo and certain of Perrigo ...

Core Viewpoint - The law firm Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Stride, Inc. for alleged violations of the Securities Exchange Act of 1934, involving misleading statements and non-disclosure of critical operational issues during the specified class period [1][3]. Summary by Sections Class Action Details - Purchasers or acquirers of Stride, Inc. securities from October 22, 2024, to October 28, 2025, have until January 12, 2026, to seek lead plaintiff status in the class action lawsuit [1]. - The lawsuit is titled MacMahon v. Stride, Inc., No. 25-cv-02019 (E.D. Va.) [1]. Allegations Against Stride - The lawsuit alleges that Stride inflated enrollment numbers by retaining "ghost students," cut staffing costs by overloading teachers, ignored compliance requirements, suppressed whistleblowers, and lost existing and potential enrollments [3]. - A complaint filed by the Gallup-McKinley County Schools Board of Education against Stride included allegations of fraud and deceptive practices, which led to a nearly 12% drop in Stride's stock price [4]. - Following a report on poor customer experience leading to higher withdrawal rates and lower conversion rates, Stride estimated a loss of 10,000-15,000 enrollments, resulting in a more than 54% decline in stock price [5]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Stride securities during the class period to seek lead plaintiff status, which enables them to act on behalf of other class members [6]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7].

LOS ANGELES--(BUSINESS WIRE)--THE LAW OFFICES OF FRANK R. CRUZANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED GAUZY Ltd. ("Gauzy†or the "Company†) (NASDAQ: GAUZ) securities between March 11, 2025 and November 13, 2025, inclusive (the "Class Period†). Gauzy investors have until February 6, 2026 to file a lead plaintiff motion. Law Offices of Frank R. Cruz Encourages Gauzy Ltd. (GAUZ) Shareholders To Inquire About Securities Fraud Class Action Share IF YOU SUFF ...

Core Viewpoint - A class action securities lawsuit has been filed against MoonLake Immunotherapeutics, alleging securities fraud that affected investors between March 10, 2024, and September 29, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements regarding MoonLake's drug candidate SLK, asserting that it shares molecular targets with BIMZELX and that SLK's unique structure does not provide superior clinical benefits [2]. - Allegations include that SLK's supposed increased tissue penetration does not translate to clinical efficacy, and thus the defendants lacked a reasonable basis for their positive claims about SLK's superiority over monoclonal antibodies [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until December 15, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Law Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years, highlighting its expertise in complex securities cases [4].

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. ("Synopsys, Inc." or the "Company") (NASDAQ: SNPS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Synopsys, Inc. investors who were adversely affected by alleged securities fraud between December 4, 2024 and September 9, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/synopsys-inc-law ...

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in StubHub Holdings, Inc. ("StubHub Holdings, Inc." or the "Company") (NYSE: STUB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of StubHub Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired StubHub common stock pursuant and/or traceable to the registration ...

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avantor, Inc. investors who were adversely affected by alleged securities fraud between March 5, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/avantor-inc-lawsuit-submi ...

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to the poor launch of its new product, Inspire V, which was marked by significant operational failures and misrepresentations to investors [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by alleged securities fraud between August 6, 2024, and August 4, 2025 [1]. - Defendants are accused of making false statements regarding the successful launch of Inspire V, while in reality, demand was low and providers had excess inventory [2]. - Key operational failures included inadequate training for treatment center customers, unestablished IT systems, and lack of Medicare reimbursement at launch [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against CarMax, Inc. alleging securities fraud that affected investors between June 20, 2025, and November 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements regarding CarMax's growth prospects, suggesting that earlier growth was a temporary benefit due to customer speculation about tariffs [2]. - It is alleged that the statements made by defendants about CarMax's business operations and prospects were materially false and misleading, lacking a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 2, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].